May 7, 2021 Pediatric COVID-19 Mitigation Strategies Virtual Workshop Click here for WebEx link On May 7th, 2021, 12:00-1:30 PM Eastern Time (US), the PRO Consortium and Rare Disease Su
Introducing Dr. Alexandre Bétourné, RDCA-DAP Scientific Director C-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelera
C-Path Launches Acute Kidney Injury Project with Support from FDA Project aims to develop improved predictive and detection tools for kidney injury TUCSON, March 25, 2021 — Acute kidney injury (
March 20, 2021 Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel
April 21, 2021 View Now | RDCA-DAP: Searching, visualizing and exploring data in the RDCA-DAP platform to identify data of interest for advanced analysis When: April 21, 2021, 12 p.m. ET Example Disease: Friedreich’s ataxia Presenters: Amanda Borens, MSc, Executiv
C-Path Names COO Kristen Swingle Interim President Joseph Scheeren departing the organization after two years of strong leadership TUCSON, Ariz., March 19, 2021 — Critical Path In
April 15, 2021-April 16, 2021 View Now: 12th Annual Patient-Reported Outcome Consortium Workshop – Held Virtually April 14–15, 2021 On April 14–15, 2021, the 12th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual f
Welcome Dr. Martijn Muller as CPP Senior Scientific Director C-Path is pleased to welcome Martijn Muller, PhD, as Senior Scientific Director for the Critical Path for Parkinson Consortium. Pr
A metadata-driven tool to determine the robustness of digital health technologies assessments for Parkinson’s Disease leveraging the voice of the patient – Sakshi Sardar, et al. Abstract # 1314